To see the other types of publications on this topic, follow the link: Proteins – Biotechnology.

Journal articles on the topic 'Proteins – Biotechnology'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Proteins – Biotechnology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lilie, Hauke. "Designer proteins in biotechnology." EMBO reports 4, no. 4 (March 14, 2003): 346–51. http://dx.doi.org/10.1038/sj.embor.embor808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Uhlén, Mathias, Göran Forsberg, Tomas Moks, Maris Hartmanis, and Björn Nilsson. "Fusion proteins in biotechnology." Current Opinion in Biotechnology 3, no. 4 (August 1992): 363–69. http://dx.doi.org/10.1016/0958-1669(92)90164-e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hodgson, John. "Proteins, biotechnology and Society." Trends in Biotechnology 6, no. 5 (May 1988): 79–80. http://dx.doi.org/10.1016/0167-7799(88)90059-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Peake, Ian. "Biotechnology of Plasma Proteins, Haemostasis, Thrombosis and Iron Proteins." Blood Coagulation & Fibrinolysis 2, no. 6 (December 1991): 779. http://dx.doi.org/10.1097/00001721-199112000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Strege, Mark A., and Avinash L. Lagu. "Capillary electrophoresis of biotechnology-derived proteins." Electrophoresis 18, no. 12-13 (1997): 2343–52. http://dx.doi.org/10.1002/elps.1150181225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jenkins, Richard O. "Proteins: Biotechnology and biochemistry: Walsh, G." Biochemistry and Molecular Biology Education 30, no. 4 (July 2002): 271–72. http://dx.doi.org/10.1002/bmb.2002.494030049998.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vizcaino-Caston, Isaac, Chris Wyre, and Tim W. Overton. "Fluorescent proteins in microbial biotechnology—new proteins and new applications." Biotechnology Letters 34, no. 2 (October 8, 2011): 175–86. http://dx.doi.org/10.1007/s10529-011-0767-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tami, Joseph A. "The Science of Biotechnology." Journal of Pharmacy Practice 11, no. 1 (February 1998): 19–27. http://dx.doi.org/10.1177/089719009801100105.

Full text
Abstract:
The quest to understand how genetic information is passed from one generation to the next reached a major milestone in the 1950s with the discovery of the complementary double-helix structure of DNA by Watson and Crick and the demonstration by Kornberg that DNA was capable of self-replication. These breakthroughs provided the stimulus for a flurry of research that culminated in a basic understanding of the genetic code and a statement of the central dogma of molecular biology: DNA goes to RNA goes to protein. In expressing a gene, RNA is formed from the DNA template in a process called transcr
APA, Harvard, Vancouver, ISO, and other styles
9

Davies, J. E. "Biotechnology 1985: From proteins to small molecules." Experientia 42, no. 1 (January 1986): 87–88. http://dx.doi.org/10.1007/bf01975911.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Šamaj, J. "Plant biotechnology employing signalling and cytoskeletal proteins." New Biotechnology 44 (October 2018): S16. http://dx.doi.org/10.1016/j.nbt.2018.05.1252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Nilsson, Björn, Göran Forsberg, Tomas Moks, Maris Hartmanis, and Mathias Uhlén. "Fusion proteins in biotechnology and structural biology." Current Opinion in Structural Biology 2, no. 4 (August 1992): 569–75. http://dx.doi.org/10.1016/0959-440x(92)90087-n.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

NILSSON, B. "Fusion proteins in biotechnology and structural biology." Current Biology 2, no. 9 (September 1992): 476. http://dx.doi.org/10.1016/0960-9822(92)90663-u.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

AD, Suleimanova. "Microbial Biotechnology Based Modified Yeast." Open Access Journal of Microbiology & Biotechnology 5, no. 1 (2020): 1–2. http://dx.doi.org/10.23880/oajmb-16000155.

Full text
Abstract:
The production of heterologous proteins, lipids and chemicals based on modified yeast is a rapidly developing area of microbial biotechnology. Methods of metabolic engineering and new technologies for editing genomes are used to create a fundamentally new high-performance industrially significant yeast strains with new properties.
APA, Harvard, Vancouver, ISO, and other styles
14

Dũng, Nguyễn Tiến, Đỗ Thị Vân Anh, Nguyễn Thị Minh Phương, Bùi Thị Huyền, Phạm Đình Minh, Đỗ Hữu Chí, Nguyễn Thị Phương Liên, Phan Văn Chi, and Lê Thị Bích Thảo. "1Institute of Biotechnology, Vietnam Academy of Science and Technology." Vietnam Journal of Biotechnology 15, no. 2 (April 20, 2018): 259–65. http://dx.doi.org/10.15625/1811-4989/15/2/12342.

Full text
Abstract:
Wasp venoms are complex mixtures of various types of compounds, of which proteins and peptides are major components. Beside its toxicity, wasp venom is potential for treatment of diseases. Characterization of venom proteins and peptides is the first and most important step toward its applications in medicine. Vietnam possesses many valuable materials, of which venoms could be used in medicine. In the present work, we aim to identify proteins and peptides in the venom of Vespa velutina (V. velutina), a species of social wasp indigenous to Southeast Asia including Vietnam using proteomic techniq
APA, Harvard, Vancouver, ISO, and other styles
15

Prausnitz, J. M. "Molecular thermodynamics for some applications in biotechnology." Pure and Applied Chemistry 75, no. 7 (January 1, 2003): 859–73. http://dx.doi.org/10.1351/pac200375070859.

Full text
Abstract:
As biotechnology sweeps the world, it is appropriate to remember that the great virtue of thermodynamics is its broad range of applicability. As a result, there is a growing literature describing how chemical thermodynamics can be used to inform processes for old and new biochemical products for industry and medicine.A particular application of molecular thermodynamics concerns separation of aqueous proteins by selective precipitation. For this purpose, we need phase diagrams; for constructing such diagrams, we need to understand not only the qualitative nature of phase equilibria of aqueous p
APA, Harvard, Vancouver, ISO, and other styles
16

Beales, Paul A., Sanobar Khan, Stephen P. Muench, and Lars J. C. Jeuken. "Durable vesicles for reconstitution of membrane proteins in biotechnology." Biochemical Society Transactions 45, no. 1 (February 8, 2017): 15–26. http://dx.doi.org/10.1042/bst20160019.

Full text
Abstract:
The application of membrane proteins in biotechnology requires robust, durable reconstitution systems that enhance their stability and support their functionality in a range of working environments. Vesicular architectures are highly desirable to provide the compartmentalisation to utilise the functional transmembrane transport and signalling properties of membrane proteins. Proteoliposomes provide a native-like membrane environment to support membrane protein function, but can lack the required chemical and physical stability. Amphiphilic block copolymers can also self-assemble into polymerso
APA, Harvard, Vancouver, ISO, and other styles
17

Panchal, R., M. Smart, D. Bowser, D. Williams, and S. Petrou. "Pore-Forming Proteins and their Application in Biotechnology." Current Pharmaceutical Biotechnology 3, no. 2 (June 1, 2002): 99–115. http://dx.doi.org/10.2174/1389201023378418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Zlobin, Nikolai E., and Vasiliy V. Taranov. "Application of bacterial cold shock proteins in biotechnology." Bulletin of the Moscow State Regional University (Natural Sciences), no. 1 (2018): 86–94. http://dx.doi.org/10.18384/2310-7189-2018-1-86-94.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Ladics, Gregory. "Safety assessment of proteins utilized in agricultural biotechnology." Toxicology Letters 229 (September 2014): S25. http://dx.doi.org/10.1016/j.toxlet.2014.06.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Service, R. F. "BIOTECHNOLOGY: Yeast Engineered to Produce Sugared Human Proteins." Science 301, no. 5637 (August 29, 2003): 1171. http://dx.doi.org/10.1126/science.301.5637.1171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Lehrer, Samuel B., W. Elliott Horner, Gerald Reese, and Steven Taylor. "Why are some proteins allergenic? Implications for biotechnology." Critical Reviews in Food Science and Nutrition 36, no. 6 (July 1996): 553–64. http://dx.doi.org/10.1080/10408399609527739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Lynch, Thomas J. "Biotechnology: alternatives to human plasma-derived therapeutic proteins." Best Practice & Research Clinical Haematology 13, no. 4 (December 2000): 669–88. http://dx.doi.org/10.1053/beha.2000.0100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Aebersold, Ruedi. "Mass spectrometry of proteins and peptides in biotechnology." Current Opinion in Biotechnology 4, no. 4 (August 1993): 412–19. http://dx.doi.org/10.1016/0958-1669(93)90006-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Mrsa, Vladimir, Antonija Grbavac, Igor Stuparevic, and Renata Teparic. "Application of surface display of proteins in biotechnology." Journal of Biotechnology 256 (August 2017): S12—S13. http://dx.doi.org/10.1016/j.jbiotec.2017.06.044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Yakimov, A. P., A. S. Afanaseva, M. A. Khodorkovskiy та M. G. Petukhov. "Design of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine". Acta Naturae 8, № 4 (15 грудня 2016): 70–81. http://dx.doi.org/10.32607/20758251-2016-8-4-70-81.

Full text
Abstract:
-Heliсes are the most frequently occurring elements of the secondary structure in water-soluble globular proteins. Their increased conformational stability is among the main reasons for the high thermal stability of proteins in thermophilic bacteria. In addition, -helices are often involved in protein interactions with other proteins, nucleic acids, and the lipids of cell membranes. That is why the highly stable -helical peptides used as highly active and specific inhibitors of protein-protein and other interactions have recently found more applications in medicine. Several different approache
APA, Harvard, Vancouver, ISO, and other styles
26

Niemeyer, Christof M. "Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science." Angewandte Chemie International Edition 40, no. 22 (November 16, 2001): 4128–58. http://dx.doi.org/10.1002/1521-3773(20011119)40:22<4128::aid-anie4128>3.0.co;2-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Graf, Alexandra, Martin Dragosits, Brigitte Gasser, and Diethard Mattanovich. "Yeast systems biotechnology for the production of heterologous proteins." FEMS Yeast Research 9, no. 3 (May 2009): 335–48. http://dx.doi.org/10.1111/j.1567-1364.2009.00507.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Peumans, Willy J., and Els J. M. Van Damme. "Plant Lectins: Versatile Proteins with Important Perspectives in Biotechnology." Biotechnology and Genetic Engineering Reviews 15, no. 1 (April 1998): 199–228. http://dx.doi.org/10.1080/02648725.1998.10647956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kennedy, John F., and Yu-Tien Lin. "Industrial Proteins in Perspective—Progress in Biotechnology Vol. 23." Carbohydrate Polymers 55, no. 1 (January 2004): 118. http://dx.doi.org/10.1016/j.carbpol.2003.08.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kumar, Awanish, Kavya Bhakuni, and Pannuru Venkatesu. "Strategic planning of proteins in ionic liquids: future solvents for the enhanced stability of proteins against multiple stresses." Physical Chemistry Chemical Physics 21, no. 42 (2019): 23269–82. http://dx.doi.org/10.1039/c9cp04772g.

Full text
Abstract:
Ionic liquids (ILs) represent as solvents or co-solvents for protein stabilization and refolding. Thus, ILs are replacement to toxic organic solvents in chemical, biotechnology and biomedical applications.
APA, Harvard, Vancouver, ISO, and other styles
31

Ningrum, Dian Eka A. F., Mohamad Amin, and Betty Lukiati. "Bioinformatics Approach Based Research of Profile Protein Carbonic Anhydrase II Analysis as a Potential Candidate Cause Autism for The Variation of Learning Subjects Biotechnology." Jurnal Pendidikan Biologi Indonesia 3, no. 1 (March 31, 2017): 28. http://dx.doi.org/10.22219/jpbi.v3i1.3799.

Full text
Abstract:
This study aims to determine the needs of learning variations on Biotechnology courses using bioinformatics approaches. One example of applied use of bioinformatics in biotechnology course is the analysis of protein profiles carbonic anhydrase II as a potential cause of autism candidate. This research is a qualitative descriptive study consisted of two phases. The first phase of the data obtained from observations of learning, student questionnaires, and questionnaires lecturer. Results from the first phase, namely the need for variations learning in Biotechnology course using bioinformatics.
APA, Harvard, Vancouver, ISO, and other styles
32

Mitchell, Daniel E., Alice E. R. Fayter, Robert C. Deller, Muhammad Hasan, Jose Gutierrez-Marcos, and Matthew I. Gibson. "Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage." Materials Horizons 6, no. 2 (2019): 364–68. http://dx.doi.org/10.1039/c8mh00727f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Haque, R. U., F. Paradisi, and T. Allers. "Haloferax volcanii for biotechnology applications: challenges, current state and perspectives." Applied Microbiology and Biotechnology 104, no. 4 (December 20, 2019): 1371–82. http://dx.doi.org/10.1007/s00253-019-10314-2.

Full text
Abstract:
AbstractHaloferax volcanii is an obligate halophilic archaeon with its origin in the Dead Sea. Simple laboratory culture conditions and a wide range of genetic tools have made it a model organism for studying haloarchaeal cell biology. Halophilic enzymes of potential interest to biotechnology have opened up the application of this organism in biocatalysis, bioremediation, nanobiotechnology, bioplastics and the biofuel industry. Functionally active halophilic proteins can be easily expressed in a halophilic environment, and an extensive genetic toolkit with options for regulated protein overexp
APA, Harvard, Vancouver, ISO, and other styles
34

Geisow, Michael J. "Characterizing Recombinant Proteins." Bio/Technology 9, no. 10 (October 1991): 921–24. http://dx.doi.org/10.1038/nbt1091-921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Nchinda, Godwin W., Nadia Al-Atoom, Mamie T. Coats, Jacqueline M. Cameron та Alain B. Waffo. "Uniqueness of RNA Coliphage Qβ Display System in Directed Evolutionary Biotechnology". Viruses 13, № 4 (27 березня 2021): 568. http://dx.doi.org/10.3390/v13040568.

Full text
Abstract:
Phage display technology involves the surface genetic engineering of phages to expose desirable proteins or peptides whose gene sequences are packaged within phage genomes, thereby rendering direct linkage between genotype with phenotype feasible. This has resulted in phage display systems becoming invaluable components of directed evolutionary biotechnology. The M13 is a DNA phage display system which dominates this technology and usually involves selected proteins or peptides being displayed through surface engineering of its minor coat proteins. The displayed protein or peptide’s functional
APA, Harvard, Vancouver, ISO, and other styles
36

Tami, Joseph A. "Major Techniques of Biotechnology." Journal of Pharmacy Practice 11, no. 1 (February 1998): 28–37. http://dx.doi.org/10.1177/089719009801100106.

Full text
Abstract:
Since the discovery of the structure and function of DNA over 40 years ago, the established knowledge of molecular biology has increased dramatically, and many new tools have been discovered and utilized by scientists to develop new therapeutic agents. Important tools that are used in recombinant DNA technology include restriction endonucleases (cleave DNA), DNA ligase (link DNA molecules together), and cloning vectors (place foreign DNA into an organism such as bacterial or yeast cells in order to mass produce the protein encoded by that foreign DNA). The development of hybridoma technology p
APA, Harvard, Vancouver, ISO, and other styles
37

Gonzalez-Vazquez, Maria Cristina, Ruth Abril Vela-Sanchez, Norma Elena Rojas-Ruiz, and Alejandro Carabarin-Lima. "Importance of Cry Proteins in Biotechnology: Initially a Bioinsecticide, Now a Vaccine Adjuvant." Life 11, no. 10 (September 23, 2021): 999. http://dx.doi.org/10.3390/life11100999.

Full text
Abstract:
A hallmark of Bacillus thuringiensis bacteria is the formation of one or more parasporal crystal (Cry) proteins during sporulation. The toxicity of these proteins is highly specific to insect larvae, exerting lethal effects in different insect species but not in humans or other mammals. The aim of this review is to summarize previous findings on Bacillus thuringiensis, including the characteristics of the bacterium, its subsequent contribution to biotechnology as a bioinsecticide due to the presence of Cry proteins, and its potential application as an adjuvant. In several studies, Cry proteins
APA, Harvard, Vancouver, ISO, and other styles
38

Han, Mee-Jung, Hongseok Yun, and Sang Yup Lee. "Microbial small heat shock proteins and their use in biotechnology." Biotechnology Advances 26, no. 6 (November 2008): 591–609. http://dx.doi.org/10.1016/j.biotechadv.2008.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Kriz, Alan L., and Brian A. Larkins. "Biotechnology of Seed Crops: Genetic Engineering of Seed Storage Proteins." HortScience 26, no. 8 (August 1991): 1036–41. http://dx.doi.org/10.21273/hortsci.26.8.1036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Amtul, Zareen, and Amal A. Aziz. "Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy." Molecular Neurobiology 54, no. 10 (December 1, 2016): 8211–24. http://dx.doi.org/10.1007/s12035-016-0279-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

King, David J. "High-performance liquid chromatography of proteins and peptides in biotechnology." TrAC Trends in Analytical Chemistry 6, no. 5 (May 1987): X—XI. http://dx.doi.org/10.1016/0165-9936(87)87050-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Fleurence, Joël. "Seaweed proteins." Trends in Food Science & Technology 10, no. 1 (January 1999): 25–28. http://dx.doi.org/10.1016/s0924-2244(99)00015-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Park, Jae W. "Seafood proteins." Trends in Food Science & Technology 5, no. 12 (December 1994): 408. http://dx.doi.org/10.1016/0924-2244(94)90176-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Selitrennikoff, Claude P. "Antifungal Proteins." Applied and Environmental Microbiology 67, no. 7 (July 1, 2001): 2883–94. http://dx.doi.org/10.1128/aem.67.7.2883-2894.2001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

GIEGE, R. "Crystallogenesis of proteins." Trends in Biotechnology 7, no. 10 (October 1989): 277–82. http://dx.doi.org/10.1016/0167-7799(89)90047-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Bush, Peggy. "Pharmacotherapeutics of Biotechnology-Derived Products." Journal of Pharmacy Practice 11, no. 1 (February 1998): 54–71. http://dx.doi.org/10.1177/089719009801100109.

Full text
Abstract:
Biotechnology has contributed to important advances in the healthcare field. Products include various hormones, enzymes, cytokines, vaccines, and monoclonal antibodies, with use in diverse therapeutic areas. The majority of approved biotechnology-derived therapeutic products are recombinant proteins. Many have orphan drug status and, therefore, are used in relatively small patient populations. Newer generation biotechnology products are likely to include small molecules, gene therapy products, and increased numbers of vaccines and monoclonal antibody products. Biotechnology provides the means
APA, Harvard, Vancouver, ISO, and other styles
47

Morley, Alec. "Biotechnology: Proteins to PCR—a course in strategies and lab techniques." Pathology 29, no. 4 (1997): 453. http://dx.doi.org/10.1016/s0031-3025(16)35008-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Nixon, Andrew E., and Steven M. Firestine. "Rational and “Irrational” Design of Proteins and Their Use in Biotechnology." IUBMB: Life 49, no. 3 (March 1, 2000): 181–87. http://dx.doi.org/10.1080/152165400306188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Nixon, Andrew, and Steven Firestine. "Rational and ?Irrational? Design of Proteins and Their Use in Biotechnology." IUBMB Life 49, no. 3 (March 1, 2000): 181–87. http://dx.doi.org/10.1080/713803615.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Strege, Mark A., and Avinash L. Lagu. "Capillary electrophoretic separations of biotechnology-derived proteins inE. coli fermentation broth." Electrophoresis 16, no. 1 (1995): 642–46. http://dx.doi.org/10.1002/elps.11501601103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!